New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2013
18:52 EDTQLIK, HRB, PKI, BIDU, EXPE, SBUX, AMZN, THRX, JCP, LOGM, FSL, CSTR, KLACOn The Fly: After Hours Movers
UP AFTER EARNINGS: Qlik Technologies (QLIK), up 13.2%... Coinstar (CSTR), up 8.5% after its quarterly report, as the company also proposed to change its name to Outerwall and trade under the ticker "OUTR"... Freescale (FSL), up 8.2%... LogMeln (LOGM), up 16.4%. ALSO HIGHER: J.C. Penney (JCP), up 6.6% after George Soros disclosed a 7.91% passive stake in the company... Theravance (THRX), up 6% after the company reported earnings and said it plans to separate its businesses into two independent publicly traded companies. DOWN AFTER EARNINGS: Amazon (AMZN), down 2%... Starbucks (SBUX), down 2.8%... Expedia (EXPE), down 4.9%... Baidu (BIDU), down 8%... PerkinElmer (PKI), down 13.9%. ALSO LOWER: H&R Block (HRB), down 4.2% after the company reported tax return volume was down 0.9% through April 18... KLA-Tencor (KLAC), down 4.9% after the company reported earnings that beat estimates, but gave fourth quarter guidance below expectations.
News For QLIK;CSTR;FSL;LOGM;JCP;THRX;AMZN;SBUX;EXPE;BIDU;PKI;HRB;KLAC From The Last 14 Days
Check below for free stories on QLIK;CSTR;FSL;LOGM;JCP;THRX;AMZN;SBUX;EXPE;BIDU;PKI;HRB;KLAC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
July 18, 2014
10:28 EDTJCPRumor: J.C. Penney moves up on renewed takeover chatter
10:03 EDTQLIKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:48 EDTAMZNActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL NQ GOOG GOOGL TSLA KGC TWTR AMZN ELNK AMGN FB
09:20 EDTEXPEExpedia checks point to potential Q2 upside, says FBR Capital
Subscribe for More Information
07:32 EDTAMZNAmazon announces Kindle Unlimited subscription service for $9.99 per month
Subscribe for More Information
07:30 EDTAMZNAmazon announces Kindle Unlimited subscription service
06:37 EDTSBUXStarbucks to test mobile phone ordering, Re/code reports
Subscribe for More Information
05:21 EDTBIDUChangyou.com appoints Rucia Ren as acting CFO
Subscribe for More Information
July 17, 2014
19:22 EDTQLIKQlik Technologies initiated with a Market Perform at BMO Capital
Subscribe for More Information
16:01 EDTAMZNOptions Update; July 17, 2014
iPath S&P 500 VIX Short-Term Futures up 2.66 to 29.93. Option volume leaders: AAPL FB GOOG APA MSFT PBR SUNE AMZN TWTR TSLA according to Track Data.
13:33 EDTAMZNAmazon.com reportedly deveoping Android app for Prime content, Cnet says
Amazon (AMZN) may soon release an app that would enable users of Google's (GOOG) Android operating system to stream content from Amazon's Prime Instant Video, PC Advisor reported, according to Cnet. Currently Amazon's Kindle Fire tablets and Apple's (AAPL) iPads are the only mobile devices that can access content from Prime, Cnet stated. Reference Link
10:46 EDTAMZNAmazon.com July weekly volatility elevated into Q2
Amazon.com July weekly call option implied volatility is at 56, August is at 37, September is at 30, October is at 28; compared to its 26-week average of 30 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on July 24.
09:40 EDTAMZNActive equity options trading on open
Subscribe for More Information
06:50 EDTAMZNAirbus considering partnering with high tech companies, NY Times says
Subscribe for More Information
06:21 EDTPKIPerkinElmer initiated with a Buy at Citigroup
Target $55.
July 16, 2014
16:00 EDTAMZNOptions Update; July 16, 2014
iPath S&P 500 VIX Short-Term Futures down 70c to 27.25. Option volume leaders: AAPL FB GOOG AMZN TWTR TSLA C HPQ TWX INTC AMZN according to Track Data.
10:58 EDTAMZNAmazon testing 'Kindle Unlimited' subscription service, Gigaom reports
Subscribe for More Information
10:00 EDTQLIKOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: American Airlines (AAL) initiated with an Overweight at Atlantic Equities... Apple (AAPL) initiated with a Buy at Citigroup... Basic Energy (BAS) initiated with a Neutral at RW Baird... Brookdale Senior Living (BKD) initiated with a Buy at Goldman... CA Technologies (CA) initiated with a Market Perform at FBR Capital... Dresser-Rand (DRC) initiated with a Neutral at RW Baird... Fortinet (FTNT) initiated with a Neutral at Goldman... Frank's International (FI) initiated with a Hold at Jefferies... Home Bancorp (HBCP) initiated with an Outperform at Fig Partners... Key Energy (KEG) initiated with an Outperform at RW Baird... McDermott (MDR) initiated with a Neutral at Tigress Financial... ORBCOMM (ORBC) initiated with a Neutral at Macquarie... Oil States (OIS) initiated with an Outperform at RW Baird... PBF Energy (PBF) initiated with an Equal Weight at Barclays... Palo Alto (PANW) assumed with a Conviction Buy at Goldman... Proofpoint (PFPT) initiated with a Buy at Goldman... Qlik Technologies (QLIK) initiated with a Market Perform at FBR Capital... Radius Health (RDUS) initiated with a Buy at Canaccord... Seventy Seven Energy (SSE) initiated with a Hold at Jefferies... Superior Energy (SPN) initiated with an Outperform at RW Baird... Tandem Diabetes (TNDM) initiated with an Outperform at William Blair... Trecora Resources (TREC) initiated with a Buy at B. Riley... Ultragenyx (RARE) initiated with an Outperform at RW Baird... United Natural Foods (UNFI) initiated with an Outperform at Oppenheimer... Viper Energy (VNOM) initiated with a Market Perform at Northland... Whiting Petroleum (WLL) initiated with a Buy at Tigress Financial.
07:55 EDTQLIKQlik Technologies initiated with a Market Perform at FBR Capital
Subscribe for More Information
05:38 EDTTHRXGSK, Theravance initiate Phase III IMPACT study
GlaxoSmithKline (GSK) and Theravance (THRX) announced the start of a global phase III study, known as IMPACT, to evaluate the efficacy and safety of the 'closed' triple combination of FF/UMEC/VI in patients with chronic obstructive pulmonary disease, or COPD. IMPACT is the first pivotal phase III study in a programme to evaluate a once-daily closed triple combination treatment of an inhaled corticosteroid, or ICS; a long-acting muscarinic antagonist, or LAMA; and a long-acting beta2-adrenergic agonist, or LABA, in patients with COPD. The IMPACT study will enrol approximately 10,000 patients and assess whether the combination of FF, or fluticasone furoate, an ICS, UMEC, or umeclidinium, a LAMA, and VI, or vilanterol, a LABA, all delivered in GSK's Ellipta inhaler, can reduce the annual rate of moderate and severe exacerbations compared with two approved once daily COPD treatments, Relvar/Breo Ellipta, FF/VI, which is an ICS/LABA combination, and Anoro Ellipta, UMEC/VI, which is a LAMA/LABA combination.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use